AMD, Absci

AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.
AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector. The effort will place particular emphasis on developing technologies that can advance drug discovery.
AMD invests $20 million in AI drug research at Vancouver-based Absci
Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial intelligence to develop new drug therapies. Absci hopes artificial intelligence will enable it to move faster to develop protein-based medicines called biologics,
Absci, AMD announce collaboration, strategic investment
Absci Corporation (ABSI) announced a strategic collaboration with AMD (AMD) to deploy AMD Instinct accelerators and ROCm software to power
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...
AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
AMD Shares Slide as HSBC Downgrades Stock Over Nvidia Concerns; Absci Collaboration Announced
Following HSBC downgrading of the semiconductor company's stock, Advanced Micro Devices ( AMD, Financials) shares fell over 5 ...
AbSci’s Strategic Growth Bolstered by AMD Collaboration and Promising Pipeline Advancements
Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on AbSci (ABSI – Research Report) and keeping the price target at ...
ABSCI股价暴涨43%：AMD投资2000万美元激活AI药物研发市场
2025年1月8日，美股盘前，ABSCI的股价大幅上涨43%，引发市场广泛关注。此次上涨的直接原因是华尔街日报报道，全球知名半导体公司AMD向人工智能驱动的药物研发公司ABSCI投资了2000万美元。这一消息不仅令ABSCI的股东欢欣鼓舞，也引发了对整个科技和医疗保健行业未来前景的深入讨论。
AMD战略携手Absci，2000万美元加码AI新药研发
近日，专注于生成式人工智能新药研发的Absci Corporation宣布了一项与AMD的战略合作计划，旨在通过部署AMD Instinct加速器和ROCm软件，为Absci的关键新药研发工作负载提供强大支持，特别是其创新的从头抗体设计模型。
Absci股价因与AMD合作和投资而飙升
Investing.com -- Absci Corporation (NASDAQ: ...
Cathie Wood’s ARK Investment buys 609K shares of Absci today
EST Cathie Wood’s ARK Investment buys 609K shares of Absci (ABSI) todayStay Ahead of the Market:Discover outperforming stocks and invest ...